News Column

Recent Findings from University of North Carolina Has Provided New Information about Nanoparticles

June 5, 2014



By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Investigators publish new report on Nanoparticles. According to news reporting originating in Chapel Hill, North Carolina, by NewsRx journalists, research stated, "Magnetic nanoparticles (MNPs) are a new and promising addition to the spectrum of biomedicines. Their promise revolves around the broad versatility and biocompatibility of the MNPs and their unique physicochemical properties."

The news reporters obtained a quote from the research from the University of North Carolina, "Guided by applied external magnetic fields, MNPs represent a cutting-edge tool designed to improve diagnosis and therapy of a broad range of inflammatory, infectious, genetic and degenerative diseases. Magnetic hyperthermia, targeted drug and gene delivery, cell tracking, protein bioseparation and tissue engineering are but a few applications being developed for MNPs. MNPs toxicities linked to shape, size and surface chemistry are real and must be addressed before clinical use is realized."

According to the news reporters, the research concluded: "This article presents both the promise and perils of this new nanotechnology, with an eye towards opportunity in translational medical science."

For more information on this research see: Bench-to-bedside translation of magnetic nanoparticles. Nanomedicine, 2014;9(4):501-516. Nanomedicine can be contacted at: Future Medicine Ltd, Unitec House, 3RD Floor, 2 Albert Place, Finchley Central, London, N3 1QB, England. (Elsevier - www.elsevier.com; Nanomedicine - www.elsevier.com/wps/product/cws_home/703416)

Our news correspondents report that additional information may be obtained by contacting D. Singh, University of North Carolina, UNC Eshelman Sch Pharm, Center Nanotechnol Drug Delivery, Chapel Hill, NC, United States. Additional authors for this research include J.M. McMillan, A.V. Kabanov, M. Sokolsky-Papkov and H.E. Gendelman (see also Nanoparticles).

Keywords for this news article include: Biotechnology, Chapel Hill, Gene Therapy, United States, North Carolina, Bioengineering, Nanotechnology, Emerging Technologies, North and Central America

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Gene Therapy Weekly


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters